(Press-News.org) Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
The research, led by the London School of Hygiene & Tropical Medicine, was carried out in Australia, Canada, Denmark, Norway, Sweden and the UK for the International Cancer Benchmarking Partnership (ICBP). The study included more than 310,000 bowel cancer patients diagnosed during 2000-07.
Bowel cancer is sometimes called colorectal cancer, which includes cancers of the colon and rectum. This study examined both types of bowel cancer.
The researchers examined how far the patients' cancer had spread at the time of diagnosis – from very early (localised, stage A) to very late (spread to other parts of the body, stage D). They also examined the proportion of patients at each stage of disease who survived for one year and three years after diagnosis, after correction for the impact of other causes of death.
Two-thirds (67%) of colon cancer patients in the UK survived for at least one year, compared with 80% in Sweden. Three-quarters (75%) of rectal cancer patients in the UK survived for one year or more, compared with 84% in Sweden.
Low overall survival in a particular country can arise either because the patients there tend to be diagnosed at a later stage of disease than in other countries, or because survival at each stage of disease is lower than in other countries.
The proportion of colon cancer patients diagnosed at the earliest stage (stage A) was lowest in the UK - only 8% compared with 11-17% elsewhere. But UK patients were also less likely to be diagnosed at the most advanced stage (20% at stage D, compared with 24-31% elsewhere).
For both colon and rectal cancer, survival among UK patients diagnosed at the earliest stage of disease (stage A) was similar to that in the other five countries (96%, compared to 92-98% elsewhere), but survival in the UK was consistently lower for those diagnosed at a more advanced stage (5-11% lower than elsewhere).
The researchers used population-based data for all patients diagnosed in a given country or region, not just the small proportion of patients included in clinical trials. The international differences in survival may arise from differences in the availability or use of diagnostic tests, and in the use of surgery, chemotherapy or radiotherapy at each stage of diagnosis. Countries do not all collect information on stage at diagnosis in the same way, however, and this can cause artefacts in international survival comparisons.
Camille Maringe, lead author based at the Cancer Research UK Cancer Survival Group at the London School of Hygiene & Tropical Medicine, said: "Accurate investigation of how far the cancer has spread (the stage) when it is diagnosed is essential for clinicians to be able to offer their patients the most appropriate treatment. This will increase survival. Investigation does not appear to be as thorough in the UK as in other countries, and except for patients with local tumours, survival is lower than in other countries at each stage of disease.
"We observed international differences in survival at each stage of disease. These differences are wider for older patients, and for patients whose disease is very advanced when they are diagnosed.
"Improvements are urgently needed in the quality and thoroughness of the medical tests that are used to assess the stage at diagnosis for each patient. The data collected by cancer registries on stage at diagnosis also need to be more accurate and complete. This will enable more accurate international comparisons of survival at each stage of disease. In turn, it will enable patients, doctors and healthcare planners to see which countries are setting the best standards, and what improvements are required to reach the highest levels of survival."
###
For media enquiries or to request a copy of the paper, contact the London School of Hygiene & Tropical Medicine press office on +44(0) 207 927 2802 or press@lshtm.ac.uk.
Notes to editor:
1. Maringe et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000 – 2007 Acta Oncologica, 2013. DOI: 10.3109/0284186X.2013.764008
2. Data were from population-based registries in Australia (New South Wales); Canada ( Alberta and Manitoba (colon); Alberta, British Columbia and Manitoba (rectum); 2004-7 only); Denmark (national, 2004-7 only), Norway (national), Sweden (Uppsala-Örebro and Stockholm-Gotland health regions); UK (Northern Ireland, and all the regional cancer registries in England (colon); Northern Ireland, and all the regional cancer registries in England except the Thames Cancer Registry (rectum)).
3. The stage at diagnosis indicates how large the cancer is, and how far it has spread when diagnosed. One of the most widely used international system for classifying the stage of bowel cancer is called Dukes' stage. This includes four stages (A-D), from tumours that are more or less localised (A, B), to those that have spread to the lymph nodes (C) or other parts of the body (D: secondary cancer or metastases).
About the International Cancer Benchmarking Partnership (ICBP)
The International Cancer Benchmarking Partnership (ICBP) is a unique and innovative global partnership of clinicians, academics and policymakers. The ICBP is funded by the UK Department of Health and Cancer Research UK. http://www.icbp.org.uk
About Cancer Research UK
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research
The charity's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years.
Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.cancerresearchuk.org.
About the London School of Hygiene & Tropical Medicine
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 3,500 students and more than 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, and was recently cited as one of the world's top universities for collaborative research. The School's mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. http://www.lshtm.ac.uk
Differences in staging and treatment likely to be behind UK's low bowel cancer survival
2013-04-17
ELSE PRESS RELEASES FROM THIS DATE:
Magnet hospitals achieve lower mortality, reports Medical Care
2013-04-17
Philadelphia, Pa. (April 16, 2013) - Lower mortality and other improved patient outcomes achieved at designated "Magnet hospitals" are explained partly—but not completely—by better nurse staffing, education, and work environment, reports a study in the May issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
"Magnet hospitals have lower mortality because of investments in nursing," comments Matthew D. McHugh, PhD, JD, MPH, RN, of University of Pennsylvania School of Nursing, Philadelphia, lead author of ...
Physician entrepreneurs are key contributors to new medical devices
2013-04-17
Philadelphia, Pa. (April 16, 2013) - Startup companies founded by physician entrepreneurs are an important source of patents used in developing innovative new medical devices, suggests a study in the May issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
"Device manufacturers gain more from the patents of physician-founded firms than from those of non-physician-founded firms in their subsequent invention and innovation efforts," according to the study by Sheryl Winston Smith, PhD, and Andrew Sfekas, PhD, ...
Softening steel problem expands computer model applications
2013-04-17
ALBUQUERQUE, N.M. — Sandia National Laboratories researchers Lisa Deibler and Arthur Brown had a ready-made problem for their computer modeling work when they partnered with the National Nuclear Security Administration's Kansas City Plant to improve stainless steel tubing that was too hard to meet nuclear weapon requirements.
When steel is too hard it becomes brittle, so the plant ended up getting new tubing. However, Deibler said KCP needed a backup in case it couldn't find replacements in time to meet deadlines.
Sandia's modeling, coupled with experiments, allowed ...
NASA imagery shows wind shear hammering Cyclone Imelda
2013-04-17
Cyclone Imelda has lost both her punch and her hurricane status as the storm moved into an area of higher wind shear and cooler waters in the Southern Indian Ocean. NASA's Aqua satellite provided an image of Imelda that showed wind shear that has been hammering the storm, had pushed the bulk of the storm's precipitation southeast of the center.
Wind shear at higher levels has increased to as high as 30 knots (34.5 mph/55.5 kph), according to upper level analysis of the atmosphere that was conducted by the Joint Typhoon Warning Center. That stronger wind shear is weakening ...
Small in size, big on power: New microbatteries the most powerful yet
2013-04-17
CHAMPAIGN, Ill. — Though they be but little, they are fierce. The most powerful batteries on the planet are only a few millimeters in size, yet they pack such a punch that a driver could use a cellphone powered by these batteries to jump-start a dead car battery – and then recharge the phone in the blink of an eye.
Developed by researchers at the University of Illinois at Urbana-Champaign, the new microbatteries out-power even the best supercapacitors and could drive new applications in radio communications and compact electronics.
Led by William P. King, the Bliss ...
Plasma device developed at MU could revolutionize energy generation and storage
2013-04-17
University of Missouri engineer Randy Curry and his team have developed a method of creating and controlling plasma that could revolutionize American energy generation and storage. Besides liquid, gas and solid, matter has a fourth state, known as plasma. Fire and lightning are familiar forms of plasma. Life on Earth depends on the energy emitted by plasma produced during fusion reactions within the sun. However, Curry warns that without federal funding of basic research, America will lose the race to develop new plasma energy technologies. The basic research program was ...
Dying supergiant stars implicated in hours-long gamma-ray bursts
2013-04-17
Three unusually long-lasting stellar explosions discovered by NASA's Swift satellite represent a previously unrecognized class of gamma-ray bursts (GRBs). Two international teams of astronomers studying these events conclude that they likely arose from the catastrophic death of supergiant stars hundreds of times larger than the sun.
VIDEO:
GRB 101225A, better known as the "Christmas burst, " was an unusually long-lasting gamma-ray burst. Because its distance ...
NASA's Wind mission encounters 'SLAMS' waves
2013-04-17
As Earth moves around the sun, it travels surrounded by a giant bubble created by its own magnetic fields, called the magnetosphere. As the magnetosphere plows through space, it sets up a standing bow wave or bow shock, much like that in front of a moving ship. Just in front of this bow wave lies a complex, turbulent system called the foreshock. Conditions in the foreshock change in response to solar particles streaming in from the sun, moving magnetic fields and a host of waves, some fast, some slow, sweeping through the region.
To tease out what happens at that boundary ...
Multicenter study confirms low testosterone in 84 percent of lung cancer patients taking crizotinib
2013-04-17
A previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib. A new study published this week in the journal Cancer confirms this finding in a multi-national sample, details the mechanism of reduced testosterone, and provides promising preliminary evidence that widely available hormone replacement therapies can alleviate this side effect in many patients.
"This was a wonderful collaboration between multiple centers confirming a side effect that had ...
Memory, the adolescent brain and lying: The limits of neuroscientific evidence in the law
2013-04-17
April 16, 2013 – San Francisco – Brain scans are increasingly able to reveal whether or not you believe you remember some person or event in your life. In a new study presented at a cognitive neuroscience meeting today, researchers used fMRI brain scans to detect whether a person recognized scenes from their own lives, as captured in some 45,000 images by digital cameras. The study is seeking to test the capabilities and limits of brain-based technology for detecting memories, a technique being considered for use in legal settings.
"The advancement and falling costs ...